Protherics announces Annual Report and Accounts
June 24 2008 - 1:22PM
Marketwired
CHESHIRE, UK , the international biopharmaceutical company
focused on critical care and cancer, announces that the Company's
Annual Report and Financial Statements for the year ended 31 March
2008, together with a Circular to Shareholders containing the
Notice of the Company's Annual General Meeting to be held at 12.00
noon on Tuesday 22 July 2008 at the offices of Ashurst LLP,
Broadwalk House, 5 Appold Street, London EC2A 2HA, have been posted
to shareholders today. In accordance with Listing Rule 9.6.1R the
following documents have been forwarded to the UK Listing Authority
and will shortly be available for inspection at The UK Listing
Authority's Document Viewing Facility, which is situated at 25 The
North Colonnade, Canary Wharf, London E14 5HS: * Protherics PLC
Annual Report and Financial Statements for the year ended 31 March
2008; * Circular to shareholders containing a Notice convening the
Company's 2008 Annual General Meeting (the "Meeting") and an
explanation of the business to be transacted at the Meeting; *
Copies of the Company's Articles of Association which contain
amendments to be proposed at the Meeting; * Rules of the Company's
new 2008 Savings Related Share Option Scheme, which is to be
submitted to shareholders for approval at the Meeting; and * A copy
of proposed amendments to the Company's 1996 Unapproved Share
Option Scheme, which are to be submitted to shareholders for
approval at the Meeting. A copy of the Company's Annual Report and
Financial Statements can be accessed on the Company's website at
www.protherics.com. / Ends / For further information please
contact: Protherics Nick Staples, Director of Corporate Affairs +44
(0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518000
Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott
+44 (0) 20 7831 3113 New York: John Capodanno, Jonathan Birt +1 212
850 5600 Or visit www.protherics.com This information is provided
by RNS The company news service from the London Stock Exchange
END
Contacts: RNS Customer Services 0044-207797-4400 Email Contact
http://www.rns.com
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Oct 2024 to Nov 2024
Protherics (NASDAQ:PTIL)
Historical Stock Chart
From Nov 2023 to Nov 2024
